A new vaccine for Covid-19 that is entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic. The vaccine, called NDV-HXP-S, is the first in clinical trials to use a new molecular design that is widely expected to create more potent antibodies than the current generation of vaccines. And the new vaccine could be far easier to make.
Existing vaccines from companies like Pfizer and Johnson & Johnson must be produced in specialized factories using hard-to-acquire ingredients. In contrast, the new vaccine can be mass-produced in chicken eggs the same eggs that produce billions of influenza vaccines every year in factories around the world.
If NDV-HXP-S proves safe and effective, flu vaccine manufacturers could potentially produce well over a billion doses of it a year. Low- and middle-income countries currently struggling to obtain vaccines from wealthier countries may be able to make NDV-HXP-S for themselves or acquire it at low cost from neighbors.
Thats staggering it would be a game-changer, said Andrea Taylor, assistant director of the Duke Global Health Innovation Center.
First, however, clinical trials must establish that NDV-HXP-S actually works in people. The first phase of clinical trials will conclude in July, and the final phase will take several months more. But experiments with vaccinated animals have raised hopes for the vaccines prospects.
Its a home run for protection, said Dr. Bruce Innis of the PATH Center for Vaccine Innovation and Access, which has coordinated the development of NDV-HXP-S. I think its a world-class vaccine.
Vaccines work by acquainting the immune system with a virus well enough to prompt a defense against it. Some vaccines contain entire viruses that have been killed; others contain just a single protein from the virus. Still others contain genetic instructions that our cells can use to make the viral protein.
Once exposed to a virus, or part of it, the immune system can learn to make antibodies that attack it. Immune cells can also learn to recognize infected cells and destroy them.
In the case of the coronavirus, the best target for the immune system is the protein that covers its surface like a crown. The protein, known as spike, latches onto cells and then allows the virus to fuse to them.
But simply injecting coronavirus spike proteins into people is not the best way to vaccinate them. Thats because spike proteins sometimes assume the wrong shape, and prompt the immune system to make the wrong antibodies.
This insight emerged long before the Covid-19 pandemic. In 2015, another coronavirus appeared, causing a deadly form of pneumonia called MERS. Jason McLellan, a structural biologist then at the Geisel School of Medicine at Dartmouth, and his colleagues set out to make a vaccine against it.
They wanted to use the spike protein as a target. But they had to reckon with the fact that the spike protein is a shape-shifter. As the protein prepares to fuse to a cell, it contorts from a tulip-like shape into something more akin to a javelin.
Scientists call these two shapes the prefusion and postfusion forms of the spike. Antibodies against the prefusion shape work powerfully against the coronavirus, but postfusion antibodies dont stop it.
Dr. McLellan and his colleagues used standard techniques to make a MERS vaccine but ended up with a lot of postfusion spikes, useless for their purposes. Then they discovered a way to keep the protein locked in a tulip-like prefusion shape. All they had to do was change two of more than 1,000 building blocks in the protein into a compound called proline.
The resulting spike called 2P, for the two new proline molecules it contained was far more likely to assume the desired tulip shape. The researchers injected the 2P spikes into mice and found that the animals could easily fight off infections of the MERS coronavirus.
The team filed a patent for its modified spike, but the world took little notice of the invention. MERS, although deadly, is not very contagious and proved to be a relatively minor threat; fewer than 1,000 people have died of MERS since it first emerged in humans.
But in late 2019 a new coronavirus, SARS-CoV-2, emerged and began ravaging the world. Dr. McLellan and his colleagues swung into action, designing a 2P spike unique to SARS-CoV-2. In a matter of days, Moderna used that information to design a vaccine for Covid-19; it contained a genetic molecule called RNA with the instructions for making the 2P spike.
Other companies soon followed suit, adopting 2P spikes for their own vaccine designs and starting clinical trials. All three of the vaccines that have been authorized so far in the United States from Johnson & Johnson, Moderna and Pfizer-BioNTech use the 2P spike.
Other vaccine makers are using it as well. Novavax has had strong results with the 2P spike in clinical trials and is expected to apply to the Food and Drug Administration for emergency use authorization in the next few weeks. Sanofi is also testing a 2P spike vaccine and expects to finish clinical trials later this year.
Dr. McLellans ability to find lifesaving clues in the structure of proteins has earned him deep admiration in the vaccine world. This guy is a genius, said Harry Kleanthous, a senior program officer at the Bill & Melinda Gates Foundation. He should be proud of this huge thing hes done for humanity.
April 7, 2021, 6:41 a.m. ET
But once Dr. McLellan and his colleagues handed off the 2P spike to vaccine makers, he turned back to the protein for a closer look. If swapping just two prolines improved a vaccine, surely additional tweaks could improve it even more.
It made sense to try to have a better vaccine, said Dr. McLellan, who is now an associate professor at the University of Texas at Austin.
In March, he joined forces with two fellow University of Texas biologists, Ilya Finkelstein and Jennifer Maynard. Their three labs created 100 new spikes, each with an altered building block. With funding from the Gates Foundation, they tested each one and then combined the promising changes in new spikes. Eventually, they created a single protein that met their aspirations.
The winner contained the two prolines in the 2P spike, plus four additional prolines found elsewhere in the protein. Dr. McLellan called the new spike HexaPro, in honor of its total of six prolines.
The structure of HexaPro was even more stable than 2P, the team found. It was also resilient, better able to withstand heat and damaging chemicals. Dr. McLellan hoped that its rugged design would make it potent in a vaccine.
Dr. McLellan also hoped that HexaPro-based vaccines would reach more of the world especially low- and middle-income countries, which so far have received only a fraction of the total distribution of first-wave vaccines.
The share of the vaccines theyve received so far is terrible, Dr. McLellan said.
To that end, the University of Texas set up a licensing arrangement for HexaPro that allows companies and labs in 80 low- and middle-income countries to use the protein in their vaccines without paying royalties.
Meanwhile, Dr. Innis and his colleagues at PATH were looking for a way to increase the production of Covid-19 vaccines. They wanted a vaccine that less wealthy nations could make on their own.
The first wave of authorized Covid-19 vaccines require specialized, costly ingredients to make. Modernas RNA-based vaccine, for instance, needs genetic building blocks called nucleotides, as well as a custom-made fatty acid to build a bubble around them. Those ingredients must be assembled into vaccines in purpose-built factories.
The way influenza vaccines are made is a study in contrast. Many countries have huge factories for making cheap flu shots, with influenza viruses injected into chicken eggs. The eggs produce an abundance of new copies of the viruses. Factory workers then extract the viruses, weaken or kill them and then put them into vaccines.
The PATH team wondered if scientists could make a Covid-19 vaccine that could be grown cheaply in chicken eggs. That way, the same factories that make flu shots could make Covid-19 shots as well.
In New York, a team of scientists at the Icahn School of Medicine at Mount Sinai knew how to make just such a vaccine, using a bird virus called Newcastle disease virus that is harmless in humans.
For years, scientists had been experimenting with Newcastle disease virus to create vaccines for a range of diseases. To develop an Ebola vaccine, for example, researchers added an Ebola gene to the Newcastle disease viruss own set of genes.
The scientists then inserted the engineered virus into chicken eggs. Because it is a bird virus, it multiplied quickly in the eggs. The researchers ended up with Newcastle disease viruses coated with Ebola proteins.
At Mount Sinai, the researchers set out to do the same thing, using coronavirus spike proteins instead of Ebola proteins. When they learned about Dr. McLellans new HexaPro version, they added that to the Newcastle disease viruses. The viruses bristled with spike proteins, many of which had the desired prefusion shape. In a nod to both the Newcastle disease virus and the HexaPro spike, they called it NDV-HXP-S.
PATH arranged for thousands of doses of NDV-HXP-S to be produced in a Vietnamese factory that normally makes influenza vaccines in chicken eggs. In October, the factory sent the vaccines to New York to be tested. The Mount Sinai researchers found that NDV-HXP-S conferred powerful protection in mice and hamsters.
I can honestly say I can protect every hamster, every mouse in the world against SARS-CoV-2, Dr. Peter Palese, the leader of the research, said. But the jurys still out about what it does in humans.
The potency of the vaccine brought an extra benefit: The researchers needed fewer viruses for an effective dose. A single egg may yield five to 10 doses of NDV-HXP-S, compared to one or two doses of influenza vaccines.
We are very excited about this, because we think its a way of making a cheap vaccine, Dr. Palese said.
PATH then connected the Mount Sinai team with influenza vaccine makers. On March 15, Vietnams Institute of Vaccines and Medical Biologicals announced the start of a clinical trial of NDV-HXP-S. A week later, Thailands Government Pharmaceutical Organization followed suit. On March 26, Brazils Butantan Institute said it would ask for authorization to begin its own clinical trials of NDV-HXP-S.
Meanwhile, the Mount Sinai team has also licensed the vaccine to the Mexican vaccine maker Avi-Mex as an intranasal spray. The company will start clinical trials to see if the vaccine is even more potent in that form.
To the nations involved, the prospect of making the vaccines entirely on their own was appealing. This vaccine production is produced by Thai people for Thai people, Thailands health minister, Anutin Charnvirakul, said at the announcement in Bangkok.
In Brazil, the Butantan Institute trumpeted its version of NDV-HXP-S as the Brazilian vaccine, one that would be produced entirely in Brazil, without depending on imports.
Ms. Taylor, of the Duke Global Health Innovation Center, was sympathetic. I could understand why that would really be such an attractive prospect, she said. Theyve been at the mercy of global supply chains.
Madhavi Sunder, an expert on intellectual property at Georgetown University Law Center, cautioned that NDV-HXP-S would not immediately help countries like Brazil as they grappled with the current wave of Covid-19 infections. Were not talking 16 billion doses in 2020, she said.
Instead, the strategy will be important for long-term vaccine production not just for Covid-19 but for other pandemics that may come in the future. It sounds super promising, she said.
In the meantime, Dr. McLellan has returned to the molecular drawing board to try to make a third version of their spike that is even better than HexaPro.
Theres really no end to this process, he said. The number of permutations is almost infinite. At some point, youd have to say, This is the next generation.
See the original post here:
Researchers Are Hatching a Low-Cost Covid-19 Vaccine - The New York Times
- The Covid-19 vaccine is free, even if you get a health insurance bill - Vox.com - April 14th, 2021
- Covid-19 Vaccine and Cases News: Live Updates - The New York Times - April 14th, 2021
- Italys Covid-19 Vaccinations Bypassed the Elderly, and More Are Dying - The Wall Street Journal - April 14th, 2021
- Only 30% of L.A. County men got COVID-19 vaccine, compared to 44% of women. Why the disparity? - Los Angeles Times - April 14th, 2021
- Sanford Health offering walk-in COVID-19 vaccinations - KELOLAND.com - April 14th, 2021
- TSC to hold student-only COVID-19 vaccination clinic - KGBT-TV - April 14th, 2021
- Chambers County is cutting back on COVID-19 vaccine appointments because fewer people are using them - KHOU.com - April 14th, 2021
- NFL says more than 2M COVID-19 vaccines administered at its stadiums - FOX 10 News Phoenix - April 14th, 2021
- Russian President Putin gets 2nd COVID-19 vaccine shot - The Associated Press - April 14th, 2021
- Thousands of COVID-19 vaccine appointments remain available in North Kansas City this week - WDAF FOX4 Kansas City - April 14th, 2021
- Covid-19: Britain Begins to Reopen, Emerging From One of the Worlds Longest Lockdowns - The New York Times - April 14th, 2021
- WATCH LIVE: White House COVID-19 Response Team to hold briefing - KING5.com - April 12th, 2021
- Will COVID-19 vaccine be mandatory? At some colleges, events and workplaces, it already is. - Chicago Tribune - April 12th, 2021
- Gov. Wolf and COVID-19 Vaccine Task Force Announce that All Adults in Pennsylvania are Eligible Tomorrow to Schedule COVID-19 Vaccination Appointments... - April 12th, 2021
- Loudoun Opens COVID-19 Vaccine to All 16 and Older - Loudoun Now - April 12th, 2021
- The Next Step in Covid-19 Vaccines May Be Through the Nose - Smithsonian Magazine - April 12th, 2021
- Pennsylvania The Latest To Announce Covid-19 Vaccines Opening To Everyone: Heres The Full List - Forbes - April 12th, 2021
- Adverse reactions to Johnson & Johnsons COVID-19 vaccine: What you need to know - WPXI Pittsburgh - April 12th, 2021
- The COVID-19 vaccines are highly effective. Heres what the numbers really mean. - The Philadelphia Inquirer - April 12th, 2021
- More Colleges Say They'll Require Students To Have COVID-19 Vaccines For Fall - NPR - April 12th, 2021
- Greece to receive first 33,600 doses of J&J COVID-19 vaccine this week - Reuters - April 12th, 2021
- Terrifying Viral Videos of Shaking After COVID-19 Vaccines Are Not What They Seem - ScienceAlert - April 12th, 2021
- We could soon have vaccines for cancer and HIV thanks to COVID-19 vaccine discovery: report - Insider - April 12th, 2021
- OSU to expand COVID-19 vaccine to students, staff this week - NBC4 WCMH-TV - April 12th, 2021
- Calumet County COVID-19 vaccine clinic will have Pfizer appointments available this week and next - Post-Crescent - April 12th, 2021
- City of Los Angeles to offer COVID-19 vaccines to those 16 and up starting Tuesday - FOX 11 Los Angeles - April 12th, 2021
- Baystate Health offering walk-in COVID-19 vaccination Monday in Holyoke - WWLP.com - April 12th, 2021
- Mainers head north for COVID-19 vaccines in reversal of normal health care trends - WGME - April 12th, 2021
- Vaccines sell out in Pakistan as the private market opens, raising concerns of inequality - CNN - April 12th, 2021
- COVID-19 vaccine: Lees Summit hosting drive-thru mass vaccination event - WDAF FOX4 Kansas City - April 12th, 2021
- COVID-19 Vaccination Sites | City of Detroit - City of Detroit - April 12th, 2021
- 'This is what you have been waiting for' | Beshear sets vaccination goal with promise to remove restrictions - WHAS11.com - April 12th, 2021
- VERIFY: What does your vaccine reaction say about how you would have fared with COVID-19? - WUSA9.com - April 12th, 2021
- Trump wants you to start calling it the 'Trumpcine' instead of the COVID-19 vaccine, report says - Business Insider - April 12th, 2021
- Nearly One-Third of Texans Have Received COVID-19 Vaccine - NBC 5 Dallas-Fort Worth - April 11th, 2021
- Charting A Policy On Covid-19 Vaccinations: What Employers Need To Know - Forbes - April 11th, 2021
- COVID-19 Vaccines Advice - World Health Organization - April 11th, 2021
- The Covid-19 vaccines are highly effective, and the chance of an adverse reaction is rare - CNN - April 11th, 2021
- COVID-19 Vaccination Clinic for New Britain Residents Open Sunday - NBC Connecticut - April 11th, 2021
- What to Know About COVID-19, Variants, and Children - Healthline - April 11th, 2021
- Native-American Tribes Pull Ahead in Covid-19 Vaccinations - The Wall Street Journal - April 11th, 2021
- One side effect of the COVID-19 vaccine could be a heavier period - The Verge - April 11th, 2021
- Phillies Rhys Hoskins wants the COVID-19 vaccine, but unsure if team can reach vaccination threshold - The Philadelphia Inquirer - April 11th, 2021
- Can you drink alcohol after getting the COVID-19 vaccine? - WGN TV Chicago - April 11th, 2021
- The story behind COVID-19 vaccines - Science Magazine - April 9th, 2021
- The Covid-19 vaccine script that TV shows are using to fight fear and misinformation - CNBC - April 9th, 2021
- Are some COVID-19 vaccines more effective than others? - Associated Press - April 9th, 2021
- In the Covid-19 vaccine push, no one is speaking Gen Z's language - STAT - April 9th, 2021
- COVID-19 vaccines and kids: What parents should know - WFLA - April 9th, 2021
- UW researchers to study COVID-19 vaccines' long-term effectiveness - KING5.com - April 9th, 2021
- Governors Should Prioritize the Covid-19 Vaccine for Everyone in Jail - brennancenter.org - April 9th, 2021
- State Focusing On Shifting COVID-19 Vaccine Allotments With Demand - 9 & 10 News - 9&10 News - April 9th, 2021
- Racial disparities and the COVID-19 vaccine rollout - KNWA - April 9th, 2021
- Fauci reveals activities he will, won't do after COVID-19 vaccination - Business Insider - April 9th, 2021
- COVID-19 vaccinations administered to over 100 homeless people in Columbus - WTVM - April 9th, 2021
- How to Handle Your COVID-19 Vaccination Card - NBC Bay Area - April 9th, 2021
- Josh Allen debating whether to get COVID-19 vaccine - NBC Sports - April 9th, 2021
- Oklahoma City VA expanding COVID-19 vaccinations to all veterans and caregivers & spouses; will hold Johnson & Johnson single dose event -... - April 9th, 2021
- Farmers and Farm Workers Should Be Prioritized for COVID-19 Vaccine - Farm Bureau News - April 7th, 2021
- Clarity still needed on effectiveness of COVID-19 vaccine passports, says UN health agency - UN News - April 7th, 2021
- Supply Of Johnson & Johnson Vaccine To Be Limited In Coming Weeks - NBC Connecticut - April 7th, 2021
- Half of US adults could have a Covid-19 vaccine dose by the weekend, but experts say it's too soon to declare victory - ABC17NEWS - ABC17News.com - April 7th, 2021
- Closing the gap - why I got the COVID-19 vaccine: Kyla Johnson - cleveland.com - April 7th, 2021
- COVID-19 vaccine appointments at TCO postponed due to weather damage - FOX 9 - April 7th, 2021
- Lost your COVID-19 vaccination card? Heres what you need to know - KHON2 - April 7th, 2021
- New COVID-19 vaccination site coming Wednesday to Elgin - Daily Herald - April 7th, 2021
- UC Davis Health Sees Big Response From Opening Up COVID-19 Vaccines To Everyone 16 And Up - Good Day Sacramento - April 7th, 2021
- A conversation on how to find that elusive Covid-19 vaccine - STAT - STAT - April 7th, 2021
- Sedgwick County man first to receive COVID-19 vaccine in his home - KSN-TV - April 7th, 2021
- 'Teenagers are seeing a glimpse of hope' with beginning of COVID-19 vaccinations - WCPO - April 5th, 2021
- A Digital COVID-19 Vaccine Passport System Is Still Premature - The Regulatory Review - April 5th, 2021
- State Farm Stadium's COVID-19 vaccination site in Glendale shifts to overnight hours to beat the heat - FOX 10 News Phoenix - April 5th, 2021
- COVID-19 Vaccine Now Available To Everyone 18+. Here's How To Get Vaccinated In Escambia County. - NorthEscambia.com - April 5th, 2021
- How COVID-19 vaccine gets from the manufacturer to your arm and why its taking so long - OCRegister - April 5th, 2021
- Hyde Co. health officials hosting COVID-19 vaccination event on April 13 - WAVY.com - April 5th, 2021
- COVID-19 Vaccination Clinics April 5-11, 2021 - West Virginia Department of Health and Human Resources - April 5th, 2021
- 200 COVID-19 vaccines going to those in underserved parts of Lee County - Wink News - April 5th, 2021
- I got the COVID-19 vaccine. What can I safely do? - MassLive.com - April 5th, 2021
- Side Effects of COVID-19 Vaccines - World Health Organization - April 5th, 2021
- Pediatric trial of COVID-19 vaccine coming to Charlotte - WCNC.com - April 5th, 2021